Temple's 186-Case Mumps Outbreak Tests the Limits of MMR Immunity

Dear Temple Community: Temple University's Student and Employee Health Services, in coordination with the Philadelphia Department of Public Health, is investigating a number of confirmed and suspected cases of mumps among Temple students. Mumps is a contagious viral illness that causes fever, headache, muscle aches, tiredness, loss of appetite, and swollen and tender salivary glands under the ears or jaw on one or both sides of the face. Most people who have received two doses of the measles, mumps, and rubella (MMR) vaccine are protected, but the vaccine is not 100% effective and immunity can wane over time. We strongly recommend that all students, faculty and staff: (1) confirm they have received two doses of MMR vaccine; (2) practice good hand hygiene and avoid sharing drinks, utensils, or vaping devices; and (3) stay home and contact a healthcare provider if they develop symptoms. Student Health Services is offering MMR vaccinations to any Temple student who has not received two documented doses.

Latest Update on Mumps Cases: As of today, the total number of confirmed and probable mumps cases connected to Temple University is 132. Temple Student and Employee Health Services and the Philadelphia Department of Public Health continue to work together to identify, isolate, and limit further transmission. Temple held a vaccination clinic last Wednesday at Mitten Hall that administered 2,285 MMR vaccinations in a single day — one of the largest single-day campus vaccination events in Temple's history. Additional clinics are scheduled. We continue to urge all students, faculty and staff to verify their MMR vaccine status. Anyone with symptoms — fever, headache, fatigue, swollen jaw or salivary glands — should self-isolate and contact a healthcare provider. Temple Student Health Services can be reached at 215-204-7500.